Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
STERILE WATER FOR INJECTION IN PLASTIC CONTAINER vs PHYSIOLYTE IN PLASTIC CONTAINER
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Water is a solvent and diluent for parenteral administration; it provides hydration and maintains osmotic balance. It has no pharmacological activity.
Physiolyte is an isotonic crystalloid solution that provides electrolytes and water to maintain or restore intravascular volume and correct fluid and electrolyte imbalances. The mechanism involves distribution of fluids between intravascular and interstitial spaces, with electrolytes contributing to osmotic balance and physiological functions.
As a diluent for reconstitution of medications,As a vehicle for intravenous administration of compatible drug additives,For hydration in patients requiring fluid replacement
Maintenance of fluid and electrolyte balance,Replacement of fluid and electrolyte losses in patients with dehydration or hypovolemia,Correction of mild metabolic acidosis (due to lactate or acetate buffer)
Intravenous administration; dose determined by clinical requirements for hydration, drug dilution, or vehicle for parenteral medications. Typical adult maintenance: 30 m L/kg/day, adjusted for electrolyte and fluid status.
Intravenous infusion; dose determined by clinical condition (e.g., dehydration, electrolyte replacement). Typical adult: 500–1000 m L as a single infusion; rate based on clinical status.
Approximately 30-45 minutes; rapid redistribution due to constant renal clearance; clinically, water half-life is not typically measured since it is a vehicle
The terminal elimination half-life of the infused crystalloid components is not applicable as a single value; the half-life of water is approximately 30–60 minutes in healthy individuals, but varies with renal function. Electrolytes have longer half-lives (e.g., Na+ ~12–24 hours). Clinical context: In renal impairment, half-life is prolonged.
Water is not metabolized; it is distributed throughout body fluids and excreted primarily by the kidneys.
The components of Physiolyte (sodium, chloride, potassium, calcium, magnesium, and acetate) are not metabolized; they are excreted primarily by the kidneys. Acetate is rapidly metabolized in the liver to bicarbonate.
Renal: >99% as free water; biliary/fecal: negligible
Physiolyte is a balanced crystalloid solution; its components (electrolytes and water) are excreted primarily via renal elimination. Water is eliminated by kidneys (urine), lungs (insensible loss), and skin (sweat). Electrolytes (Na+, K+, Ca2+, Mg2+, Cl-, acetate, gluconate) are predominantly excreted renally with minimal biliary or fecal elimination (<5%).
0% (water does not bind to plasma proteins)
The components of Physiolyte (electrolytes) do not significantly bind to plasma proteins; protein binding is negligible (<5%).
0.55-0.7 L/kg (total body water); clinically, water distributes throughout total body water
Volume of distribution for crystalloid solutions is approximately 0.2–0.25 L/kg for water and electrolytes, corresponding to the extracellular fluid volume. Clinical meaning: Rapid redistribution from intravascular to interstitial space (about 75% leaves vasculature within 1 hour).
Intravenous: 100%; subcutaneous: ~100% (complete absorption); intramuscular: ~100%
Intravenous: 100% bioavailability. Not administered orally.
No specific GFR-based dose adjustment; monitor fluid balance and avoid fluid overload in renal impairment. In oliguric or anuric patients (GFR <10 m L/min), reduce volume to match insensible losses plus urine output.
No specific dose adjustment; use with caution in renal impairment due to risk of fluid/electrolyte overload. Monitor serum electrolytes and renal function.
No specific Child-Pugh based modification; use with caution in ascites or edema due to risk of fluid overload.
No specific dose adjustment; use with caution in hepatic impairment due to potential fluid/electrolyte imbalances.
Weight-based: Neonates and infants: 60-100 m L/kg/day for maintenance; adjust for dehydration or ongoing losses. Administer via intravenous route.
Intravenous infusion; dose determined by weight and clinical condition. Typical: 20–30 m L/kg as a single infusion; adjust based on ongoing losses and maintenance requirements.
Use lower end of dosing range due to decreased renal function and comorbidities; monitor for fluid overload and electrolyte disturbances. Typical starting dose: 20-30 m L/kg/day intravenously.
Use with caution due to increased risk of fluid overload and electrolyte disturbances; monitor renal function and fluid status; adjust rate and volume as needed.
None.
None.
Use only if solution is clear and container is intact,Do not use for intravenous injections that require isotonic solutions unless additives are used to achieve isotonicity,Risk of hemolysis if administered as a large volume hypotonic solution,Monitor for fluid overload in patients with renal impairment or cardiac disease
Use with caution in patients with congestive heart failure, renal impairment, or conditions that may cause fluid overload,Monitor serum electrolytes, fluid balance, and renal function during therapy,Not recommended for use in neonates or infants without careful monitoring due to risk of hypernatremia,Avoid rapid or large-volume infusions in patients with compromised cardiovascular or renal function
Known hypersensitivity to any component,Use as a large volume intravenous infusion without appropriate additives to achieve isotonicity
Hypersensitivity to any component,Severe renal impairment (anuria or oliguria),Hyperkalemia (for solutions containing potassium),Hypermagnesemia (for solutions containing magnesium),Hypercalcemia (for solutions containing calcium),Severe metabolic alkalosis,Concurrent administration with certain drugs that may cause adverse interactions (e.g., potassium-sparing diuretics, ACE inhibitors)
No known food interactions. Patients on a sodium-restricted diet should be aware that this product contains no sodium.
No specific food interactions. However, consider the patient's overall fluid and electrolyte status; avoid excessive intake of sodium or potassium-rich foods if electrolyte imbalances are present.
Sterile Water for Injection is a parenteral fluid devoid of pharmacologic activity. There is no known teratogenic risk across all trimesters; water is an essential nutrient with no expected fetal harm when administered appropriately.
Physiolyte is a balanced electrolyte solution. No teratogenic effects reported. Considered low risk in all trimesters when used as directed.
Compatible with breastfeeding; water distributes into breast milk without known adverse effects. No M/P ratio applicable as it is a non-medicinal vehicle.
Physiolyte is an electrolyte solution; its components are normal constituents of breast milk. M/P ratio not applicable. Considered compatible with breastfeeding.
No dose adjustment needed; water clearance and distribution remain unchanged in pregnancy.
No specific dose adjustments required for pregnancy. Monitor for altered fluid requirements due to physiologic changes.
Sterile water for injection is not intended for direct intravenous administration; it is used for reconstitution of medications or as a diluent. If given intravenously without proper tonicity adjustments, it can cause hemolysis, hyponatremia, and cerebral edema.
Physiolyte (balanced electrolyte solution) is isotonic with plasma and contains acetate as a buffer. Do not administer with blood products due to risk of clotting. Monitor serum electrolytes, renal function, and fluid balance during infusion. Caution in patients with heart failure, renal impairment, or hyperkalemia.
This product is used to mix with other medications before they are given as an injection or infusion.,Do not inject this water directly into a vein as it can cause serious side effects.,Tell your healthcare provider if you have any allergies or if you are on a sodium-restricted diet.
This solution is used to replace fluids and electrolytes in your body.,Tell your healthcare provider if you have kidney disease, heart disease, or are on a low-salt diet.,Report any signs of fluid overload: shortness of breath, swelling, or rapid weight gain.,Do not mix this solution with other medications unless directed by your provider.,This product is sterile and for single use only; discard any unused portion.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about STERILE WATER FOR INJECTION IN PLASTIC CONTAINER vs PHYSIOLYTE IN PLASTIC CONTAINER, answered by our medical review team.
STERILE WATER FOR INJECTION IN PLASTIC CONTAINER is a Irrigation Solution that works by Water is a solvent and diluent for parenteral administration; it provides hydration and maintains osmotic balance. It has no pharmacological activity.. PHYSIOLYTE IN PLASTIC CONTAINER is a Irrigation Solution that works by Physiolyte is an isotonic crystalloid solution that provides electrolytes and water to maintain or restore intravascular volume and correct fluid and electrolyte imbalances. The mechanism involves distribution of fluids between intravascular and interstitial spaces, with electrolytes contributing to osmotic balance and physiological functions.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between STERILE WATER FOR INJECTION IN PLASTIC CONTAINER and PHYSIOLYTE IN PLASTIC CONTAINER depend on the specific clinical indication. These are both Irrigation Solution agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of STERILE WATER FOR INJECTION IN PLASTIC CONTAINER is: Intravenous administration; dose determined by clinical requirements for hydration, drug dilution, or vehicle for parenteral medications. Typical adult maintenance: 30 m L/kg/day, adjusted for electrolyte and fluid status.. The standard adult dose of PHYSIOLYTE IN PLASTIC CONTAINER is: Intravenous infusion; dose determined by clinical condition (e.g., dehydration, electrolyte replacement). Typical adult: 500–1000 m L as a single infusion; rate based on clinical status.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between STERILE WATER FOR INJECTION IN PLASTIC CONTAINER and PHYSIOLYTE IN PLASTIC CONTAINER in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. STERILE WATER FOR INJECTION IN PLASTIC CONTAINER is classified as Category C. Sterile Water for Injection is a parenteral fluid devoid of pharmacologic activity. There is no known teratogenic risk across all trimesters; water is an essential nutrient with no. PHYSIOLYTE IN PLASTIC CONTAINER is classified as Category C. Physiolyte is a balanced electrolyte solution. No teratogenic effects reported. Considered low risk in all trimesters when used as directed.. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.